Article
Impact of the MTHFR C677T polymorphism on one-carbon metabolites: Evidence from a randomised trial of riboflavin supplementation.
Biochimie - 1 Jun 2020
Rooney Martina, Bottiglieri Teodoro, Wasek-Patterson Brandi, McMahon Amy, Hughes Catherine F, McCann Adrian, Horigan Geraldine, Strain J J, McNulty Helene, Ward Mary
Abstract excerpt
Homozygosity for the C677T polymorphism in MTHFR (TT genotype) is associated with a 24-87% increased risk of hypertension. Blood pressure (BP) lowering was previously reported in adults with the TT genotype, in response to supplementation with the MTHFR cofactor, riboflavin. Whether the BP phenotype associated with the polymorphism is related to perturbed one-carbon metabolism is unknown. This study investigated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
